The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2024
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kostyuk G.P.

Alekseev Psychiatric Clinical Hospital No. 1

Golubev S.A.

Gannushkin Psychiatric Clinical Hospital No. 4;
Mental Health Research Centre

Masyakin A.V.

Ministry of Health of the Moscow region

Shumakova E.A.

Gannushkin Psychiatric Clinical Hospital No. 4

Allenov A.M.

City policlinic N 210;
Sechenov First Moscow State Medical University

Mamatenko Yu.A.

Metronom Ltd

Comorbidity of somatic diseases in psychiatric patients

Authors:

Kostyuk G.P., Golubev S.A., Masyakin A.V., Shumakova E.A., Allenov A.M., Mamatenko Yu.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(1): 77‑83

DOI: 10.17116/jnevro202112101177

Views: 4980

Downloaded: 94

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Kostyuk GP, Golubev SA, Masyakin AV, Shumakova EA, Allenov AM, Mamatenko YuA. Comorbidity of somatic diseases in psychiatric patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(1):77‑83. (In Russ.)
https://doi.org/10.17116/jnevro202112101177

Подписка 2025 (S.S. Korsakov Journal of Neurology and Psychiatry)
 
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Mediasphera_Net
Close metadata
Recommended articles:
Como­rbidity patterns and stru­cture of depressive episodes in patients with bipo­lar diso­rder and major depressive diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(11-2):108-114
Orga­nic mental diso­rders with como­rbid alco­holism in the elde­rly. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(12):27-33
Mental diso­rders in blepharospasm. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(12):76-82
Mental diso­rders, social and demo­graphic characteristics of patients with chro­nic and episodic migraine. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(1):94-101
Alexithymia and self-harm in people with borderline personality diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(1):102-108
Algo­rithm of alle­rgic rhinitis treatment in patients with various types of nasal septum deviation. Russian Rhinology. 2023;(4):238-244
Reflux nephropathy and pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2023;(6):12-18
Clinical and diagnostic significance of soma­tic diseases skin mani­festations. Russian Journal of Preventive Medi­cine. 2023;(11):98-108
Cardiovascular risk asse­ssment tools in patients with type 2 diabetes mellitus. Russian Journal of Preventive Medi­cine. 2023;(11):109-115
Choroidal changes in patients with diabetes mellitus. Russian Annals of Ophthalmology. 2023;(6):158-165

OBJECTIVE

To study the prevalence of somatic diseases in patients with mental disorders based on the results of medical examination in Moscow mental health clinics in 2018.

MATERIAL AND METHODS

A retrospective analysis of the results of the clinical examinations of 6492 outpatients, which accounted for 79.5% of patients who underwent medical examination in this time period.

RESULTS

Comorbid somatic diseases were found in 4883 (75%) patients. Hypertension and non-insulin-dependent diabetes mellitus were most frequent with the prevalence higher than in the general population of the Russian Federation. Patients with diagnosed schizophrenia, along with hypertension and diabetes mellitus, have found to be at increased risk of diseases of the endocrine system and metabolic disorders. The incidence of the mentioned diseases is not higher than that reported in literature.

CONCLUSION

The higher prevalence of socially relevant diseases (hypertension, diabetes mellitus) among patients with mental disorders demands the development of strategies for prevention, early detection and treatment of these diseases in psychiatric patients.

Keywords:

mental disorders
somatic diseases
paranoid schizophrenia
hypertension
diabetes mellitus
comorbidity

Authors:

Kostyuk G.P.

Alekseev Psychiatric Clinical Hospital No. 1

Golubev S.A.

Gannushkin Psychiatric Clinical Hospital No. 4;
Mental Health Research Centre

Masyakin A.V.

Ministry of Health of the Moscow region

Shumakova E.A.

Gannushkin Psychiatric Clinical Hospital No. 4

Allenov A.M.

City policlinic N 210;
Sechenov First Moscow State Medical University

Mamatenko Yu.A.

Metronom Ltd

Received:

11.05.2020

Accepted:

11.05.2020

List of references:

  1. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry. 2000;177:212–217.  https://doi.org/10.1192/bjp.177.3.212
  2. Mortensen P, Juel K. Mortality and causes of death in schizophrenic patients in Denmark. Acta Psychiatr Scand. 1990;81(4):372–377.  https://doi.org/10.1111/j.1600-0447.1990.tb05466.x
  3. Anderson C, Connelly J, Johnstone EC, Owens DG. Disabilities and circumstances of schizophrenic patients--a follow-up study. Cause of death. Br J Psychiatry Suppl. 1991;(13):30–3, 44–6. 
  4. Newman S, Bland R. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can J Psychiatry. 1991;36(4):239–245.  https://doi.org/10.1177/070674379103600401
  5. Brook OH. Mortality in the long-state population of Dutch mental hospitals. Acta Psychiatr Scand. 1985;71(6):626–635.  https://doi.org/10.1111/j.1600-0447.1985.tb02558.x
  6. Herrman H, Baldwin JA, Christie D. A record-linkage study of mortality and general hospital discharge in patients diagnosed as schizophrenic. Psychol Med. 1983;13(3):581–593.  https://doi.org/10.1017/s0033291700048005
  7. Jones DR, Macias C, Barreira PJ, et al. Prevalence, severity, and co-occurrence of chronic physical health problems of persons with serious mental illness. Psychiatr Serv. 2004;55(11):1250–1257. https://doi.org/10.1176/appi.ps.55.11.1250
  8. Samele C, Lawton-Smith S, Warner L, Mariathasan J. Patient choice in psychiatry. Br J Psychiatry. 2007;191:1–2.  https://doi.org/10.1192/bjp.bp.106.031799
  9. Dixon L, Weiden P, Delahanty J, et al. Prevalence and Correlates of Diabetes in National Schizophrenia Samples. Schizophr Bull. 2000;26(4):903–912.  https://doi.org/10.1093/oxfordjournals.schbul.a033504
  10. Meyer J, Nasrallah H, McEvoy J, et al. The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome. Schizophr Res. 2005;80(1):9–18.  https://doi.org/10.1016/j.schres.2005.07.015
  11. Osborn D, Marston L, Nazareth I, et al. Relative risks of cardiovascular disease in people prescribed olanzapine, risperidone and quetiapine. Schizophr Res. 2017;183:116–123.  https://doi.org/10.1016/j.schres.2016.11.009
  12. Hippisley-Cox J, Vinogradova Y, Coupland C, Parker C. Risk of Malignancy in Patients With Schizophrenia or Bipolar Disorder. Arch Gen Psychiatry. 2007;64(12):1368–1376. https://doi.org/10.1001/archpsyc.64.12.1368
  13. Mallinger J, Lamberti J. Clozapine-Should race affect prescribing guidelines? Schizophr Res. 2006;83(1):107–108.  https://doi.org/10.1016/j.schres.2006.01.017
  14. Omotoso BA, Abdel-Rahman EM, Scully K, et al. Major Depression: A Risk Factor for Long-Term Major Cardiovascular Events (MACE) and Mortality in Acute Kidney Injury. Am J Kidney Dis. 2016;67(5):A82.  https://doi.org/10.1053/j.ajkd.2016.03.261
  15. Federal’naya sluzhba gosudarstvennoi statistiki. Zabolevaemost’ naseleniya sotsial’no-znachimymi boleznyami (dannye Minzdrava Rossii, raschet Rosstata). Accessed Jan 18, 2021. (In Russ.). https://rosstat.gov.ru/folder/13721
  16. Kostyuk GP, Shmukler AB, Golubev SA, et al. Epidemiological aspects of diagnosis of schizophrenia in Moscow. Sotsial’naya i klinicheskaya psikhiatriya. 2017;27(3):5–9. (In Russ.).
  17. Sokolov RE. The role of gender in the formation of manifest schizophrenic psychoses in adolescents. Neurosci Behav Physi. 2012;42:855–861.  https://doi.org/10.1007/s11055-012-9649-0

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register


We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.